Nucleic acid sample preparation consumables include extraction kits, purification reagents, buffers, clean-up kits, quantification consumables, and workflow-compatible components used to isolate and prepare DNA and RNA for downstream molecular analysis.
These consumables are essential in molecular diagnostics, infectious disease testing, oncology, genomics research, precision medicine, PCR, qPCR, and next-generation sequencing (NGS). High-quality DNA and RNA extraction is critical for accurate, reproducible, and reliable test results.
According to BIS Research, the global nucleic acid sample preparation consumables market was valued at $1,762.4 million in 2024 and is projected to reach $2,816.8 million by 2035, growing at a CAGR of 4.37% during the forecast period 2025-2035.
Download the complete TOC and Request Sample Report
• Growing number of genetic tests across diagnostics and research
• Rising prevalence of infectious diseases and cancer
• Increasing use of qPCR, PCR, NGS, cloning, and microbial sequencing
• Growing adoption of automation-compatible extraction and purification consumables
• Demand for high-throughput, accurate, scalable, and standardized molecular workflows
• High cost of advanced sample preparation consumables
• Stringent regulatory and quality compliance requirements
• Need for workflow standardization across diverse laboratory settings
• Concerns around genomic data privacy, protection, and ethical use
• Operational complexity in integrating consumables with automated platforms
• October 2025: AutoGen, Inc. partnered with Sampled to deliver next-generation nucleic acid extraction and multi-omic workflows.
• October 2025: LGC Biosearch Technologies, Inc. opened a new National Laboratories facility in Guildford to support broader R&D and service capabilities.
• September 2025: Promega Corporation partnered with Watchmaker Genomics to license a next-generation engineered reverse transcriptase to enhance RNA analysis performance.
o U.A.E.
o South Africa
o Rest-of-Middle East and Africa
According to Research Analyst – BIS Research: “The nucleic acid sample preparation consumables market is poised for significant growth, driven by the increasing prevalence of infectious diseases and cancer, the growing number of genetic tests, and the rapid expansion of microbial sequencing and next-generation sequencing (NGS) applications. As healthcare and research systems increasingly prioritize precision medicine, early disease detection, and high-throughput diagnostics, nucleic acid sample preparation has become a critical step in ensuring accuracy and reliability across molecular workflows.
Technological advancements in automation, high-efficiency reagents, and magnetic particle-based technologies are transforming sample preparation processes by improving yield consistency, reducing manual intervention, and enabling scalability across clinical and research settings. These innovations are supporting faster processing, better sample quality, and seamless integration with downstream applications such as qPCR and NGS, which are central to modern diagnostics and genomics research.
With ongoing investments in genomics, expanding laboratory infrastructure, and increasing adoption across emerging markets, the nucleic acid sample preparation consumables market presents strong opportunities for innovation and global expansion. Companies that focus on automation compatibility, cost-effective solutions, and standardized workflows are expected to gain a competitive edge while supporting improved research outcomes and diagnostic efficiency.”
The market is projected to grow from $1,835.9 million in 2025 to $2,816.8 million by 2035, at a CAGR of 4.37% during 2025-2035.
The DNA segment is expected to dominate, supported by high demand for DNA extraction kits and growing use of DNA in NGS, PCR, cloning, and restriction enzyme analysis.
Key players include Agilent Technologies, Inc., AutoGen Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., Promega Corporation, Zymo Research, LGC Biosearch Technologies, and Danaher Corporation.
BIS Research provides expert-driven insights, granular segmentation, and strategic advisory across healthcare, life sciences, diagnostics, genomics, and deep technology domains.
